TY - JOUR
T1 - Treatments for Acute Nonarteritic Central Retinal Artery Occlusion
T2 - Findings From a Cochrane Systematic Review
AU - Lin, John C.
AU - Song, Sophia L.
AU - Ng, Sueko M.
AU - Scott, Ingrid U.
AU - Greenberg, Paul B.
N1 - Publisher Copyright:
© 2023 Slack Incorporated. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Many interventions for nonarteritic central retinal artery occlusion (CRAO) are associated with serious complications and little effect on visual outcomes. We report on the findings of a Cochrane systematic review that searched seven databases for peer-reviewed articles reporting on treatments for acute nonarteritic CRAO. We assessed six randomized controlled trials, including interventions such as tissue plasminogen activator (t-PA), isovolumic hemodilution, eyeball massage, intraocular pressure reduction, anticoagulation, vasodilation, oxygen inhalation, laser embolysis, transcorneal electrical stimulation, thrombolysis, pentoxifylline, and enhanced external counterpulsation. However, none of the randomized controlled trials demonstrated significant improvement in visual acuity at 1 month compared to observation, and some patients treated with t-PA experienced serious adverse effects including intracranial hemorrhage. Proposed interventions for acute nonarteritic CRAO may not be better than observation, but the evidence is uncertain. Larger, well-designed studies are necessary to determine the most effective management option for acute nonarteritic CRAO.
AB - Many interventions for nonarteritic central retinal artery occlusion (CRAO) are associated with serious complications and little effect on visual outcomes. We report on the findings of a Cochrane systematic review that searched seven databases for peer-reviewed articles reporting on treatments for acute nonarteritic CRAO. We assessed six randomized controlled trials, including interventions such as tissue plasminogen activator (t-PA), isovolumic hemodilution, eyeball massage, intraocular pressure reduction, anticoagulation, vasodilation, oxygen inhalation, laser embolysis, transcorneal electrical stimulation, thrombolysis, pentoxifylline, and enhanced external counterpulsation. However, none of the randomized controlled trials demonstrated significant improvement in visual acuity at 1 month compared to observation, and some patients treated with t-PA experienced serious adverse effects including intracranial hemorrhage. Proposed interventions for acute nonarteritic CRAO may not be better than observation, but the evidence is uncertain. Larger, well-designed studies are necessary to determine the most effective management option for acute nonarteritic CRAO.
UR - http://www.scopus.com/inward/record.url?scp=85176977932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176977932&partnerID=8YFLogxK
U2 - 10.3928/23258160-20230922-01
DO - 10.3928/23258160-20230922-01
M3 - Review article
C2 - 37855834
AN - SCOPUS:85176977932
SN - 2325-8160
VL - 54
SP - 650
EP - 653
JO - Ophthalmic Surgery Lasers and Imaging Retina
JF - Ophthalmic Surgery Lasers and Imaging Retina
IS - 11
ER -